Company news

Latigo Biotherapeutics, Inc. (NASDAQ:LTGO) news

Latigo Biotherapeutics, Inc. news releases on 6ix. Latest, Sep 3, 2026: LTGO: Onzotrigine delivers rapid, superior pain relief with strong opioid-sparing…

View Latigo Biotherapeutics, Inc. →

Press releases & updates

LTGO: Onzotrigine delivers rapid, superior pain relief with strong opioid-sparing potential in late-stage trials

September 3, 2026

Latigo Biotherapeutics Price Target Announced at $36.00/Share by Leerink Partners

September 1, 2026

Latigo Biotherapeutics Ups IPO to 19.2 Million Shares

August 7, 2026